Takeda is heading to the FDA with positive PhIII results for HyQvia in rare autoimmune disease
Eight years into its marketing odyssey, Takeda says it’s ready to pitch HyQvia for a new indication.
Late last week Takeda — which wound up with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
